Xencor (XNCR) Return on Equity [ROE] (2014 - 2026)
Xencor's Return on Equity [ROE] came in at -32.06% for Q2 2026, down 4.59 percentage points from -27.47% a year earlier and down 2.11 percentage points from the prior quarter.
Xencor (XNCR) Return on Equity [ROE] (2014 - 2026) Analysis & Trends
For FY2025, Xencor's Return on Equity [ROE] was -14.07%, up 21.34 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of -2.17 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was -35.41% in FY2024 (-16.22 pp), -19.19% in FY2023 (-11.63 pp), -7.55% in FY2022 (-20.21 pp) and 12.65% in FY2021 (+24.55 pp).
- The Q2 2026 figure represents the lowest quarterly Return on Equity [ROE] since Q1 2025.
- Year-over-year, Return on Equity [ROE] increased in four of the last eight quarters, with an average year-over-year change of -0.39 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q1 2022 (a gain of 22.45 percentage points), and the weakest in Q1 2023 (a drop of 28.08 percentage points).
- Business Quant data shows XNCR's Return on Equity [ROE] at -29.95% (Q1 2026), -14.61% (Q4 2025) and -21.14% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Xencor | 2.94 Bn | 1.37 Bn | - | -22.16% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -22.16% |
| Jun 30, 2026 | -32.06% |
| Mar 31, 2026 | -29.95% |
| Dec 31, 2025 | -14.61% |
| Sep 30, 2025 | -21.14% |
| Jun 30, 2025 | -27.47% |
| Mar 31, 2025 | -32.13% |
| Dec 31, 2024 | -34.28% |
| Sep 30, 2024 | -34.54% |
| Jun 30, 2024 | -33.69% |
| Mar 31, 2024 | -23.24% |
| Dec 31, 2023 | -20.03% |
| Sep 30, 2023 | -17.66% |
| Jun 30, 2023 | -18.72% |
| Mar 31, 2023 | -19.78% |
| Dec 31, 2022 | -7.21% |
| Sep 30, 2022 | 4.48% |
| Jun 30, 2022 | 3.37% |
| Mar 31, 2022 | 9.14% |
| Dec 31, 2021 | 5.84% |
Xencor Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=XNCR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "XNCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=XNCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();